Targeting autophagic initiation <em>via</em> both ULK1 and Beclin-1/VPS34 complexes increases chemotherapeutic potency in PDAC. — ASN Events
  1. Schedule
  2. Lunch & Poster Viewing (Odd Numbers)
  3. Targeting autophagic initiation via both ULK1 and Beclin-1/VPS34 complexes increases chemotherapeutic potency in PDAC.

Targeting autophagic initiation via both ULK1 and Beclin-1/VPS34 complexes increases chemotherapeutic potency in PDAC. (#115)

Josef Gillson 1 2 , Sumit Sahni 1 2 3
  1. Bill Walsh Laboratory, Kolling Institute, St Leonards, NSW, Australia
  2. Medicine and Health, University of Sydney, Camperdown, NSW, Australia
  3. Australian Pancreatic Cancer Centre, St Leonards, NSW, Australia
Publish consent withheld
#NSWCancerConf2023